Kids' antipsychotic weight gain tracked for years in major safety study
NCT ID NCT03522168
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This completed study followed 509 children aged 3 to 18 who were taking risperidone or aripiprazole for conditions like schizophrenia or bipolar disorder. Researchers measured weight changes over up to 50 months to understand long-term risks. The goal was to provide better safety information for doctors and families.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- risperidone (Risperdal) and aripiprazole (Abilify)
- What this could lead to
- If successful, this study could help doctors better understand and manage long-term weight gain in children taking these antipsychotic medications.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly improve health. Results may not apply to all children or medications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISTIC DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AMR-Baber Research, Inc.
Naperville, Illinois, 60563, United States
-
Arkansas Children's Research Institute
Little Rock, Arkansas, 72202, United States
-
Attalla Consultants LLC dba Institute for Behavioral Medicine
Smyrna, Georgia, 30082, United States
-
Avera McKennan University Psychiatry Associates
Sioux Falls, South Dakota, 57108, United States
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Beacon Medical Group
South Bend, Indiana, 46601, United States
-
Behavioral Health Hospital Oupatient Clinic
Greensboro, North Carolina, 27278, United States
-
BioBehavioral Research of Austin
Austin, Texas, 78759, United States
-
Carolina Partners in Mental HealthCare, PLLC
Raleigh, North Carolina, 27609, United States
-
Clinical Trials Solution
Miami, Florida, 33126, United States
-
Cone Health Outpatient Behavioral Health
Greensboro, North Carolina, 27403, United States
-
Cook Children's Medical Center
Fort Worth, Texas, 76104, United States
-
Duke Child and Family Study Center
Durham, North Carolina, 27705, United States
-
Harmonex Neuroscience Research
Dothan, Alabama, 36303, United States
-
IACT Health
Grayson, Georgia, 30017, United States
-
Kennedy Krieger Institute
Baltimore, Maryland, 21205, United States
-
Le Bonheur Children's Hospital
Memphis, Tennessee, 38103, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Massachusetts General Hospital, Lurie Center for Autism
Lexington, Massachusetts, 02421, United States
-
Montefiore Medical Center, Albert Einstein College of Medicine
The Bronx, New York, 10461, United States
-
Neurobehavioral Medicine Group
Bloomfield, Michigan, 48302, United States
-
Neuropsychiatric Associates
Woodstock, Vermont, 05091, United States
-
OM Research
Lancaster, California, 93594, United States
-
Pine Rest Christian Mental Health Services
Grand Rapids, Michigan, 49548, United States
-
Scientific Clinical Research, Inc.
North Miami, Florida, 33161, United States
-
South Florida Behavioral Health Network
Miami, Florida, 33126, United States
-
Southwest Autism Research & Resource Center
Phoenix, Arizona, 85006, United States
-
UCLA Semel Institute
Los Angeles, California, 90024, United States
-
University of Cincinnati
Cincinnati, Ohio, 45219-2492, United States
-
University of Massachusetts Medical School
Worcester, Massachusetts, 01655, United States
-
University of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68131, United States
-
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
-
University of Virginia
Charlottesville, Virginia, 22903, United States
-
Valley Healthcare System
Columbus, Georgia, 31903, United States
-
Washington University
St Louis, Missouri, 63110, United States
-
Yale Child Study Center
New Haven, Connecticut, 06520, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Can a new daily pill offer safer Long-Term control of schizophrenia?
- Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?
- Can a dissolving film tame agitation in schizophrenia?
- Can a phone app teach the brain to read social cues?
- Can a gentle brain current silence voices that medication Can't?